Verici DX
VRCI · AIM · Health Care · mcap £5.1m · 0.2p
Oberon Investments Limited
1 Jul · 1 notice
below 3% → 15.2%
share price at the notices 0.4p · now 0.2p
1 Jul 2026
Harwood Capital LLP
24 Jun · 1 notice
12.0% → 12.8%
share price at the notices 0.4p · now 0.2p
24 Jun 2026
Puma Investment Management Limited
23 Jun · 1 notice
10.5% → 10.5%
share price at the notices 0.4p · now 0.2p
23 Jun 2026
Canaccord Genuity Group Inc
24 Jun · 1 notice
6.9% → 10.4%
share price at the notices 0.4p · now 0.2p
24 Jun 2026
UBS Group AG - Investment Bank & Global Wealth Management
30 Mar – 18 Sep · 17 notices
7.8% → 8.9%
share price at the notices 0.2–0.5p · now 0.2p
30 Mar 2026 7 Apr 2026 10 Apr 2026 24 Apr 2026 30 Apr 2026 11 May 2026 11 May 2026 13 May 2026 22 May 2026 27 May 2026 2 Jun 2026 4 Jun 2026 19 Jun 2026 25 Jun 2026 4 Aug 2026 27 Aug 2026 18 Sep 2026
Pentwater Capital Management LP
24 Jun · 1 notice
7.8% → 8.9%
share price at the notices 0.4p · now 0.2p
24 Jun 2026
Unicorn Asset Management Limited
24 Jun · 1 notice
7.9% → 8.3%
share price at the notices 0.4p · now 0.2p
24 Jun 2026
Seneca Partners Limited
24 Jun · 1 notice
6.8% → 4.9%
share price at the notices 0.4p · now 0.2p
24 Jun 2026
Directors
No open-market share purchases by directors in 12 months.
other Verici Dx plc announced the appointment of Aubrey Powell as a Non-executive Director, effective immediately. Concurrently, Dr. Erik Lium, who had served as a Non-executive Director since August 2020, stepped down from th 6 Oct 2025
other Verici Dx Plc announced that Non-Executive Director James McCullough has resigned from the Board with immediate effect to focus on his CEO role at Renalytix plc, and the company has commenced its search for a replacement 31 Mar 2026
Company filings. Not investment advice.